Community-Acquired Pneumonia
Treatment of community-acquired pneumonia in adults, according to the approved product information.
Levofloxacin
FLULOCIN is a levofloxacin antibacterial indicated in adults for the treatment of infections caused by susceptible bacteria, according to the approved product information.
Levofloxacin 750 mg regimens are used in adults for selected bacterial infections. Treatment should take account of local guidance and bacterial susceptibility.
Treatment of community-acquired pneumonia in adults, according to the approved product information.
Treatment of acute bacterial sinusitis in adults.
Treatment of complicated urinary tract infection and acute pyelonephritis in adults.
Treatment of complicated skin and skin-structure infections in adults.
Treatment of nosocomial pneumonia in adults.
Levofloxacin is a fluoroquinolone antibacterial agent that acts on the bacterial DNA gyrase complex and topoisomerase IV.
How Flulocin works
Flulocin®Levofloxacin DNA Gyrase and Topoisomerase IV Bacterial DNA Synthesis Inhibition Bactericidal ActivityLevofloxacin is rapidly and almost completely absorbed after oral administration; absolute bioavailability is 99–100%.
Use only for infections proven or strongly suspected to be caused by susceptible bacteria, in line with local guidance.
Fluoroquinolones may cause tendinitis and tendon rupture, peripheral neuropathy and central nervous system effects. Use approved product information for complete warnings.
Do not use in patients with hypersensitivity to levofloxacin or other quinolones, epilepsy, or a history of fluoroquinolone-related tendon disorders.
FLULOCIN is a levofloxacin antibacterial indicated in adults for the treatment of infections caused by susceptible bacteria, according to the approved product information.
Levofloxacin 750 mg regimens are used in adults for selected bacterial infections: community-acquired pneumonia, acute bacterial sinusitis, complicated urinary tract infection and acute pyelonephritis, complicated skin and skin-structure infections, and nosocomial pneumonia. Treatment should take account of local guidance and bacterial susceptibility.
Levofloxacin is a fluoroquinolone antibacterial agent that acts on the bacterial DNA gyrase complex and topoisomerase IV.
Administer orally every 24 hours when a 750 mg regimen is indicated. Dose and duration depend on the type and severity of infection and the susceptibility of the presumed pathogen. Adjust the dose in patients with renal impairment (creatinine clearance <50 mL/min).
Levofloxacin is rapidly and almost completely absorbed after oral administration; absolute bioavailability is 99–100%.
Use only for infections proven or strongly suspected to be caused by susceptible bacteria, in line with local guidance.
Fluoroquinolones may cause tendinitis and tendon rupture, peripheral neuropathy and central nervous system effects. Use approved product information for complete warnings. Do not use in patients with hypersensitivity to levofloxacin or other quinolones, epilepsy, or a history of fluoroquinolone-related tendon disorders.
Flulocin is available as Levofloxacin 500 mg and 750 mg, in boxes of 5 or 30 tablets, following the United States Pharmacopeia standard.
The 750 mg dossier specifies levofloxacin hemihydrate USP equivalent to levofloxacin 750 mg per film-coated tablet. Finished-product testing references the United States Pharmacopeia.